ISSN: 2155-9880
+44 1300 500008
Lysia Matius Gressida, Krida Wacana and Natalia Liem
Christian University, Indonesia
Singapore General Hospital, Singapore
Halen United Investment Pte Ltd., Singapore
Posters & Accepted Abstracts: J Clin Exp Cardiolog
According to World Health Organization (WHO), the mortality from coronary heart disease in Indonesia reached 138,380 or 10% of total deaths per year in 2014. Dyslipidemias are disorders of lipoproteins that can be manifested by the elevation of serum total cholesterol, Low-Density Lipoprotein (LDL) cholesterol and triglyceride concentrations and a decrease in the High-Density Lipoprotein (HDL) cholesterol concentration. Hydroponic therapy (drinking of mineral water), in particular water that is rich in natural bicarbonate has shown to have an eff ect in reducing cholesterolaemic and lipaemic levels by increasing the lipoprotein metabolism. Th is study compares the consumption of a mineral water that is rich in natural bicarbonate (ARDESY�?�?�?®, France) (MWH) versus a marketed mineral water that is low in bicarbonate (MWL) and their eff ects in lipoprotein metabolism in high cholesterol males subjects. Twenty-two (22) males with elevated serum total cholesterol and a mean BMI of between 23.9�?�?�?±4.4 kg/m2 were randomized into 2 groups. Each group received either (MWH) (n=14) (sponsored by ARDESY�?�?�?®, France), or MWL (n=8). Subjects drank 1.25 liter of designated water per day for 28 weeks. Th ree visits were planned at the clinical center post screening, which included fi rst day before mineral water was consumed (V1), 15th day (V2), and 29th day (V3). Results indicated that there was signifi cant reduction in serum total cholesterol (p=0.002) and LDL cholesterol (p<0.001) in subjects drinking MWH, but not in the MWL group. Th ere was no signifi cant change in BMI, blood pressure and urine pH. In conclusion, regular consumption of rich bicarbonated water can signifi cantly lower total cholesterol and LDL-c in moderate risk cholesterol males. Validation in a randomized control trial is currently underway.
Lysia Matius Gressida has graduated with Bachelor of Medical Science from the Christian University of Krida Wacana, Indonesia in 2011 and later earned her General Practitioner degree in 2012. She currently works as a General Practitioner in Primary Healthcare under the Ministry of Health, Indonesia. She is a Registered Member of the Indonesian Medical Association. Her experiences included, Internship program in Tondano, North Sulawesi, certiï¬ ed courses in Advanced Cardiology, Trauma and Neurology Life Support. Her primary interests are in preventive medicine and she has a personal advocacy in promoting awareness of maintaining healthy lifestyles through patients’ education.